Virtual Workshop A – Keeping Canada in the Clinical Development Pipeline: Strengthening Evidence Generation and Market Access
Canada faces growing competition for global clinical trial investment, with implications for pharmaceutical innovation, research capacity and patient access to emerging therapies. Attracting and retaining clinical trial investment requires a competitive research environment and the ability to generate evidence relevant to Canadian regulatory, HTA and payer needs.
This workshop will explore how Canada can strengthen its position as a clinical research destination and better connect clinical development with future market access.
- Identifying barriers to attracting and retaining global clinical trial investment
- Exploring opportunities to strengthen Canada’s clinical research environment
- Aligning evidence-generation strategies with Canadian regulatory, HTA and payer requirements
- Examining how locally relevant evidence can inform future reimbursement and patient access